Andrew Chadeayne

https://caam.tech/team/

Dr. Andrew Chadeayne is the Founder and CEO of CaaMTech, which is leading the charge to map the chemical and patent landscapes of the psychedelics space.

CaaMTech

Founder, CEO

Bis (4-acetoxy-N, N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug

Psilocybin

AR Chadeayne, JA Golen, DR Manke - … Crystallographica Section E …, 2019 - scripts.iucr.org

iucr.org

Compositions and methods comprising a psilocybin derivative

Psilocybin

AR Chadeayne - US Patent App. 15/893,562, 2018 - Google Patents

googleapis.com

Compositions comprising a psilocybin derivative and a cannabinoid

Psilocybin

AR Chadeayne - US Patent App. 16/192,736, 2019 - Google Patents

googleapis.com

Last updated: Apr 16, 2021

Request Deletion

Andrew Chadeayne

Organizations

Research